This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ciardo, F. Articles by Curatolo, P. Search for Related Content PubMed PubMed Citation Articles by Ciardo, F. Articles by Curatolo, P. Social Bookmarking                         What's this?

Topical Review : Neurologic Aspects of Adenylosuccinate Lyase Deficiency

Department of Neuroscience Pediatric Neurology Unit, "Tor Vergata" University of Rome

Costantino Salerno, MD

Department of Human Biopathology "La Sapienza" University of Rome, Rome, Italy

Paolo Curatolo, MD

Department of Neuroscience Pediatric Neurology Unit, "Tor Vergata" University of Rome, curatolo{at}seneca.uniroma2.it

Adenylosuccinate lyase deficiency is an autosomal-recessive disorder of the purine de novo synthesis pathway, diagnosed up to now in approximately 40 patients. The clinical presentation is characterized by severe neurologic involvement including seizures, developmental delay, hypotonia, and autistic features. Neonatal seizures and a severe infantile epileptic encephalopathy are often the first manifestations of this disorder. The existence of genetic heterogeneity for the adenylosuccinate lyase defect could account for variability of the clinical presentation. Deficiency of purine nucleotides, impairment of energy metabolism, and toxic effects are potential mechanisms of cerebral damage. Laboratory investigations show the presence in urine and cerebrospinal fluid of succinylpurines, which are normally undetectable. Currently, no effective treatment is available for adenylosuccinate lyase deficiency. A search for this disorder should be included in the screening program of children with unexplained neonatal seizures or severe infantile epileptic encephalopathy. (J Child Neurol 2001;16:301-308).

Journal of Child Neurology, Vol. 16, No. 5, 301-308 (2001)
DOI: 10.1177/088307380101600501


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				B. Manzi, A. L. Loizzo, G. Giana, and P. Curatolo Autism and Metabolic Diseases J Child Neurol, March 1, 2008; 23(3): 307 - 314. [Abstract] [PDF]